Active ingredients: normal immunoglobulin
What it is used for
KIOVIG administered intravenously is indicated for: (1) Replacement therapy indications - Primary immunodeficiency disorders (PID); - Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. (2) Immunomodulation indications - Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count; - Guillain Barre syndrome; - Kawasaki Disease. - Multifocal Motor Neuropathy KIOVIG administered subcutaneously is indicated for: (1) Replacement therapy indications - Primary immunodeficiency disorders (PID);
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store at 2 to 8 degrees Celsius
- Do not Freeze
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems